Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)

NCT01099124 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: M2ES

Sponsor

Tianjin Medical University Cancer Institute and Hospital